RVX-297
RVX-297 is a potent, orally active BET bromodomain inhibitor with selectivity for BD2. RVX-297 shows IC50s of 0.08, 0.05, and 0.02 μM for BRD2 (BD2), BRD3 (BD2), and BRD4 (BD2), respectively. RVX-297 suppresses inflammatory gene expression in multiple immune cell types. RVX-297 is effective in acute inflammation and autoimmunity models[1][2].
Product Specifications
CAS Number
1044871-04-6
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rvx-297.html
Purity
95.00
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1NC(C2=CC(C)=C(OCCN3CCCC3)C(C)=C2)=NC4=C1C(OC)=CC(OC)=C4
Molecular Formula
C24H29N3O4
Molecular Weight
423.50
Precautions
H302, H312, H332
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD2; BRD3; BRD4; BRDT
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Uncoated Human MFGE8 (Milk Fat Globule EGF Factor 8) ELISA Kit
Uncoated Human MFGE8 (Milk Fat Globule EGF Factor 8) ELISA Kit
